These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33093444)

  • 1. LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis.
    Li F; Chen Q; Xue H; Zhang L; Wang K; Shen F
    Cell Death Dis; 2020 Oct; 11(10):894. PubMed ID: 33093444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.
    Shuai Y; Ma Z; Liu W; Yu T; Yan C; Jiang H; Tian S; Xu T; Shu Y
    Mol Cancer; 2020 Jan; 19(1):6. PubMed ID: 31924214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC-Activated LncRNA
    Wu QN; Luo XJ; Liu J; Lu YX; Wang Y; Qi J; Liu ZX; Huang QT; Liu ZK; Lu JB; Jin Y; Pu HY; Hu PS; Zheng JB; Zeng ZL; Ju HQ; Xie D; Zhao Q; Xu R
    Cancer Res; 2021 May; 81(10):2636-2650. PubMed ID: 33782099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer.
    Liu S; Li H; Zhu Y; Ma X; Shao Z; Yang Z; Cai C; Wu Z; Li M; Gong W; Wu X
    Cancer Lett; 2022 Oct; 547():215862. PubMed ID: 35953000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc-Mediated Cell-Cycle Progression and Proliferation in Lung Cancer.
    Zhu Q; Zhang C; Qu T; Lu X; He X; Li W; Yin D; Han L; Guo R; Zhang E
    Cancer Res; 2022 Dec; 82(23):4340-4358. PubMed ID: 36214649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA AFAP1-AS1 Promoted Tumor Growth and Invasion in Cholangiocarcinoma.
    Lu X; Zhou C; Li R; Deng Y; Zhao L; Zhai W
    Cell Physiol Biochem; 2017; 42(1):222-230. PubMed ID: 28535506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
    Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
    Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA MNX1-AS1 Promotes Glioblastoma Progression Through Inhibition of miR-4443.
    Gao Y; Xu Y; Wang J; Yang X; Wen L; Feng J
    Oncol Res; 2019 Feb; 27(3):341-347. PubMed ID: 29678219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
    Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
    Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
    Ji D; Wang Y; Sun B; Yang J; Luo X
    Biochem Biophys Res Commun; 2019 Jun; 513(3):669-674. PubMed ID: 30982576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/BRF2 pathway.
    Liu H; Han L; Liu Z; Gao N
    J Cell Physiol; 2019 Aug; 234(8):13843-13850. PubMed ID: 30618167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
    Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
    J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
    Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
    Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MNX1-AS1: A novel oncogenic propellant in cancers.
    Li T; Zhou S; Yang Y; Xu Y; Gong X; Cheng Y; Wang Y
    Biomed Pharmacother; 2022 May; 149():112801. PubMed ID: 35290890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer.
    Lv Y; Li H; Li F; Liu P; Zhao X
    Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A.
    Ma JX; Yang YL; He XY; Pan XM; Wang Z; Qian YW
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4756-4762. PubMed ID: 31210302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma.
    Ye Y; Gu B; Wang Y; Shen S; Huang W
    J Cell Biochem; 2019 Apr; 120(4):6145-6153. PubMed ID: 30362161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of lncRNA TP73-AS1 predicts adverse phenotypes for cholangiocarcinoma and exerts oncogenic properties in vitro and in vivo.
    Yao Y; Sun Y; Jiang Y; Qu L; Xu Y
    Biomed Pharmacother; 2018 Oct; 106():260-266. PubMed ID: 29966969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer.
    Li AH; Zhang HH
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5618-5623. PubMed ID: 29271994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA MNX1-AS1 functions as a competing endogenous RNA to regulate epithelial-mesenchymal transition by sponging MiR-744-5p in colorectal cancer.
    Huang S; Sun Y
    Biosci Biotechnol Biochem; 2021 Feb; 85(3):568-578. PubMed ID: 33590038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.